Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Nicola A Hanania, Scott H Bunner, Lindsay GS Bengtson, Afisi S Ismaila & Michael Bogart. (2023) COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 407-418.
Read now
Read now
Richard H. Stanford, Nicole M. Engel-Nitz, Timothy Bancroft & Breanna Essoi. (2020) The Identification and Cost of Acute Chronic Obstructive Pulmonary Disease Exacerbations in a United States Population Healthcare Claims Database. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:5, pages 499-508.
Read now
Read now
David Singer, Lindsay G S Bengtson, Caitlin Elliott, Ami R Buikema & Jessica Franchino-Elder. (2020) Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3239-3250.
Read now
Read now
Charlie Strange, Valery Walker, Michael DePietro, Junliang Tong, Jonathan Kurlander, Maureen Carlyle, Lauren A Millette & Eric Wittbrodt. (2019) Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1377-1388.
Read now
Read now
Jason C Simeone, Rakesh Luthra, Shuchita Kaila, Xiaoyun Pan, Tarun D Bhagnani, Jieruo Liu & Teresa K Wilcox. (2017) Initiation of triple therapy maintenance treatment among patients with COPD in the US. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 73-83.
Read now
Read now
Tzy-Chyi Yu, Huanxue Zhou, Kangho Suh & Stephen Arcona. (2015) Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease. ClinicoEconomics and Outcomes Research 7, pages 37-51.
Read now
Read now
Gene L Colice. (2012) Pragmatic research and outcomes in asthma and COPD. Pragmatic and Observational Research 3, pages 11-25.
Read now
Read now
Kathryn Fitch, Kosuke Iwasaki, Bruce Pyenson, Craig Plauschinat & Jie Zhang. (2011) Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis. Current Medical Research and Opinion 27:7, pages 1425-1429.
Read now
Read now
Articles from other publishers (13)
Sanjay SethiSwetha R PalliLindsay G S BengtsonErin K BuysmanBrendan ClarkAndrew SargentAsif ShaikhGary T Ferguson. (2023) Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol. Journal of Managed Care & Specialty Pharmacy 29:7, pages 791-806.
Crossref
Crossref
Criner Gerard, Fernando Martinez, Hitesh Gandhi, Bruce Pyenson, Norbert Feigler, Matthew Emery, Umang Gupta & Muthiah Vaduganathan. (2023) PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population. Journal of Health Economics and Outcomes Research.
Crossref
Crossref
Gerard Criner, Fernando Martinez, Hitesh Gandhi, Norbert Feigler, Bruce Pyenson, Matthew Emery, Umang Gupta & Muthiah Vaduganathan. (2023) PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population. Journal of Health Economics and Outcomes Research 10:1.
Crossref
Crossref
Izumi Kawachi, Hiromichi Otaka, Kosuke Iwasaki, Tomomi Takeshima & Kengo Ueda. (2022) A Principal Component Analysis Approach to Estimate the Disability Status for Patients with Multiple Sclerosis Using Japanese Claims Data. Neurology and Therapy 11:1, pages 385-396.
Crossref
Crossref
Swetha R PalliBin XieBenjamin ChastekCaitlin A ElliottLindsay G S Bengtson. (2021) Comparison of COPD health care utilization and associated costs across patients treated with LAMA+LABA fixed-dose therapies. Journal of Managed Care & Specialty Pharmacy 27:7, pages 810-824.
Crossref
Crossref
Swetha R PalliSiting ZhouAsif ShaikhVincent J Willey. (2021) Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy. Journal of Managed Care & Specialty Pharmacy 27:5, pages 625-637.
Crossref
Crossref
Allison Keshishian, Lin Xie, Carole Dembek & Huseyin Yuce. (2019) Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators. Clinical Therapeutics 41:11, pages 2283-2296.
Crossref
Crossref
Jennifer S. Albrecht, Bilal Khokhar, Ting-Ying Huang, Yu-Jung Wei, Ilene Harris, Patience Moyo, Peter Hur, Susan W. Lehmann, Giora Netzer & Linda Simoni-Wastila. (2017) Adherence and healthcare utilization among older adults with COPD and depression. Respiratory Medicine 129, pages 53-58.
Crossref
Crossref
S. Garcia-Gutierrez, J. M. Quintana, A. Bilbao, A. Unzurrunzaga, C. Esteban, M. Baré, R. M. Girón Moreno, E. Pulido & P. Rivas. (2014) Validity of criteria for hospital admission in exacerbations of COPD. International Journal of Clinical Practice 68:7, pages 820-829.
Crossref
Crossref
Dendy Macaulay, Shawn X. Sun, Rachael A. Sorg, Sherry Y. Yan, Gourab De, Eric Q. Wu & Paul F. Simonelli. (2013) Development and validation of a claims-based prediction model for COPD severity. Respiratory Medicine 107:10, pages 1568-1577.
Crossref
Crossref
Linda Simoni-Wastila, Yu-Jung Wei, Jingjing Qian, Ilene H. Zuckerman, Bruce Stuart, Thomas Shaffer, Anand A. Dalal & Lynda Bryant-Comstock. (2012) Association of Chronic Obstructive Pulmonary Disease Maintenance Medication Adherence With All-Cause Hospitalization and Spending in a Medicare Population. The American Journal of Geriatric Pharmacotherapy 10:3, pages 201-210.
Crossref
Crossref
Wouter D van Dijk, Lisette van den Bemt, Saskia van den Haak-Rongen, Erik Bischoff, Chris van Weel, Johannes CCM in 't Veen & Tjard RJ Schermer. (2011) Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respiratory Research 12:1.
Crossref
Crossref
Edmond L. Toy, Nicolas U. Beaulieu, Joshua M. McHale, Timothy R. Welland, Craig A. Plauschinat, Andrine Swensen & Mei Sheng Duh. (2011) Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costs. Respiratory Medicine 105:3, pages 435-441.
Crossref
Crossref